p110δ Isoform of PI3 Kinase in Tumor Endothelium
In the article on p110δ Isoform of PI3 Kinase in Tumor Endothelium in the July 15, 2004 issue of Cancer Research (1), the name of one of the contributing authors, Jeffrey Brousal, was missing. The correct list of authors should read: Ling Geng, Jiahuai Tan, Eric Himmelfarb, Aaron Schueneman, Ken Niermann, Jeffrey Brousal, Allie Fu, Kyle Cuneo, Edward A. Kesicki, Jennifer Treiberg, Joel S. Hayflick, and Dennis E. Hallahan. Dr. Brousal’s affiliation is the Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee.
1. Geng L, Tan J, Himmelfarb E, Schueneman A, Niermann K, Brousal J, Fu A, Cuneo K, Kesicki EA, Treiberg J, Hayflick JS, Hallahan DE. A specific antagonist of the p110δ catalytic component of phosphatidylinositol 3′-kinase, IC486068, enhances radiation-induced tumor vascular destruction. Cancer Res 2004;64:4893–9
